Prostaglandin transporter (PGT) mediates
prostaglandin (PG) catabolism and PG signal termination. The
prostanoid PGE(2), which induces angiogenesis and vasodilation, is diminished in diabetic skin, suggesting that PGT up-regulation could be important in wound healing deficiency, typified by
diabetic foot ulcer. We hypothesized that up-regulation of PGT in
hyperglycemia could contribute to weakened
PGE(2) signaling, leading to impaired angiogenesis and wound healing. In human dermal microvascular endothelial cells (HDMECs), exposure to
hyperglycemia increased PGT expression and activity up to threefold, accompanied by reduced levels of
PGE(2).
Hyperglycemia reduced HDMEC migration by 50% and abolished tube formation. Deficits in
PGE(2) expression, HDMEC migration, and tube formation could be corrected by treatment with the PGT inhibitor T26A, consistent with the idea that PGT hyperactivity is responsible for impairments in angiogenesis mediated by PG signaling. In vivo, PGT expression was profoundly induced in diabetes and by wounding, correlating with diminished levels of proangiogenic factors
PGE(2) and
VEGF in cutaneous
wounds of diabetic mice. Pharmacological inhibition of PGT corrected these deficits. PGT inhibition shortened cutaneous
wound closure time in diabetic mice from 22 to 16 days. This effect was associated with increased proliferation, re-epithelialization, neovascularization, and blood flow. These data provide evidence that
hyperglycemia enhances PGT expression and activity, leading to diminished angiogenic signaling, a possible key mechanism underlying defective wound healing in diabetes.